Atomoxetine
Strattera (atomoxetine) is a prescription medication classified as a selective norepinephrine reuptake inhibitor, used primarily to treat attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults. Unlike many other ADHD medications, it is not a stimulant and is not classified as a controlled substance, making it an option for patients who may not respond well to or prefer to avoid stimulants.
Strattera is a non-stimulant ADHD medication that works by affecting norepinephrine levels in the brain.
Key facts at a glance
- RxNorm
- 358330
- Generic
- Strattera
- Class
- brand-name
- Brands
- —
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Strattera is FDA-approved for the treatment of ADHD in patients aged 6 years and older, including children, adolescents, and adults. It may be used as part of a comprehensive treatment program that includes psychological, educational, and social measures.
Strattera is a selective norepinephrine reuptake inhibitor. It works by blocking the reuptake of norepinephrine, a neurotransmitter, increasing its availability in the brain. This is believed to improve attention, impulse control, and reduce hyperactive and impulsive behaviors associated with ADHD.
Strattera is typically taken once or twice daily as directed by a healthcare provider. Common side effects may include decreased appetite, nausea, dry mouth, and fatigue. Rare but serious risks include liver problems and suicidal thoughts in young people. It is not a controlled substance and has different abuse potential than stimulant medications. Patients should be monitored for psychiatric symptoms, especially when starting treatment.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 9, 2026. · Read our editorial policy